Peripheral nerve stimulator Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes, DelveInsight | B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwave LLC, Vygon, Medilogix

The global Peripheral Nerve Stimulators market is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2024 to 2030. The rising demand for Peripheral Nerve Stimulators is mainly driven by an increase in patients suffering from nerve injuries, advancements in PNS technologies, greater public awareness about peripheral nerve stimulators, and the growing need for chronic pain management therapies. Other contributing factors include the rising prevalence of diseases that cause pain, an expanding geriatric population, a growing number of obese individuals, and heightened awareness about PNS. These factors are expected to support market growth and contribute to the expansion of the Peripheral Nerve Stimulation Device market during the forecast period.

DelveInsight's Peripheral nerve stimulator Market Insights report provides the current and forecast market analysis, individual leading Peripheral nerve stimulator companies' market shares, challenges, Peripheral nerve stimulator market drivers, barriers, and trends, and key Peripheral nerve stimulator companies in the market.

Download our sample report on peripheral nerve stimulators @ https://www.delveinsight.com/report-store/peripheral-nerve-stimulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Peripheral nerve stimulator Market Report
The Peripheral nerve stimulator market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Peripheral nerve stimulator market during the forecast period.
Notable Peripheral nerve stimulator companies such as B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwave LLC, Vygon, Medilogix, and several others are currently operating in the Peripheral nerve stimulator market.
The Peripheral Nerve Stimulators market is witnessing a surge in product demand, driven by several factors, with one of the key reasons being the rising prevalence of various chronic diseases and the growing need for drug discovery related to these conditions.
In July 2024, Curonix received FDA clearance for its Freedom® PNS System, the first full-body peripheral nerve stimulator, including a craniofacial pain indication. This system marks a significant milestone in PNS technology, expanding treatment options for patients with diverse pain profiles.
In January 2024, Neuralace Medical received FDA clearance for its Axon Therapy, a non-invasive magnetic PNS treatment for chronic painful diabetic neuropathy (PDN). This therapy delivers painless, 13.5-minute sessions using magnetic pulses, offering a promising alternative to traditional pain management methods.
In April 2023, Neuspera Medical introduced the first leadless micro-implant for chronic peripheral nerve pain management. This ultra-miniaturized system provides neurostimulation therapy through a wireless platform, enhancing patient comfort and procedural flexibility.
Leading companies in the Peripheral Nerve Stimulators market include B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwave LLC, Vygon, Medilogix, and others.

To read more about the latest highlights related to the Peripheral nerve stimulator market, get a snapshot of the key highlights entailed in the Global Peripheral nerve stimulator Market Report https://www.delveinsight.com/sample-request/peripheral-nerve-stimulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Peripheral nerve stimulator Overview

Peripheral Nerve Stimulators (PNS) are medical devices used to treat chronic pain and nerve-related disorders by delivering electrical impulses to specific peripheral nerves. These devices are designed to alleviate pain, improve nerve function, and support the recovery process, particularly in patients with conditions such as neuropathic pain, chronic pain, and nerve injuries.

Peripheral nerve stimulator Market Insights

North America is expected to hold the largest share in the global Peripheral Nerve Stimulators (PNS) market. This is driven by factors such as the rising prevalence of chronic pain, the approval and increased awareness of PNS devices, and a growing geriatric population.

Physical health issues, including chronic pain, are particularly prevalent among adults aged 65 to 84 years, with conditions such as high BMI, diabetes, renal problems, and hypertension contributing to this. According to the 2019 National Health Interview Survey data, 20.4% of U.S. adults reported chronic pain, with 7.4% experiencing high-impact chronic pain that significantly limited their daily life and work activities. Chronic pain was more common in women (21.7%) compared to men (19.0%), and high-impact chronic pain was also higher in women (8.5% vs. 6.3% in men). Pain levels were found to be the highest among individuals aged 65 and older.

These factors are expected to drive the growth of the PNS market in North America.

To know more about why North America is leading the market growth in the Peripheral nerve stimulator market, get a snapshot of the Peripheral nerve stimulator Market Outlook https://www.delveinsight.com/report-store/peripheral-nerve-stimulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Peripheral nerve stimulator Market Dynamics

The Peripheral Nerve Stimulators (PNS) market is segmented by product type, end-user, and geography. The product types include implants and percutaneous devices, while end-users consist of hospitals, ambulatory surgical centers, and others. The geographical regions covered are North America, Europe, Asia-Pacific, and the Rest of the World.

Among the product types, implantable peripheral nerve stimulators are expected to dominate the market during the forecast period (2024-2030). Implantable PNS involves the subcutaneous implantation of electrodes near or on the peripheral nerve causing pain, delivering electrical signals to alleviate discomfort. The advantages of implants include a minimally painful implantation procedure, reduced procedure time, and a decrease in opioid usage for pain management.

Key developments in the market include Neuspera Medical Inc. receiving FDA approval for the Neuspera Neurostimulation System (NNS) in August 2021, a device aimed at providing pain relief. Additionally, in February 2022, Nalu Medical updated its "Haleakalā" system to expand the stimulation pulse width, enhancing its capabilities for both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS).

Factors such as increasing chronic pain cases, the growing geriatric and obese populations, and rising public awareness of PNS are anticipated to drive the demand for these devices, contributing to the overall growth of the market during the forecast period.

Peripheral nerve stimulator Market Drivers:

Increased product demand for several reasons
Growing occurrence of various chronic diseases and the substantial demand for drug discovery related to these conditions


Get a sneak peek at the Peripheral nerve stimulator market dynamics @ https://www.delveinsight.com/sample-request/peripheral-nerve-stimulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Coverage: Global
Study Period: 2022 to 2032
Key Peripheral nerve stimulator Companies: B. Braun Melsungen AG, Bioventus, AVNS, Nalu Medical Inc, Stimwave LLC, Vygon, Medilogix, and others.

Which MedTech key players in the Peripheral nerve stimulator market are set to emerge as the trendsetter, explore @ Peripheral nerve stimulator Companies https://www.delveinsight.com/report-store/peripheral-nerve-stimulators-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Table of Contents

1. Peripheral nerve stimulator Market Report Introduction
2. Peripheral nerve stimulator Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Peripheral nerve stimulator Market Key Factors Analysis
6. Peripheral nerve stimulator Market Porter's Five Forces Analysis
7. Peripheral nerve stimulator Market Layout
8. Peripheral nerve stimulator Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact us:

Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.